Eli Lilly and Company's direct cost for Zepbound is not publicly disclosed. However, the manufacturer's suggested retail price (MSRP) for Zepbound is $1,059.87 for a one-month supply of pens [1]. This price is for the medication itself and does not account for potential savings programs or insurance coverage.
How much does Zepbound cost with insurance?
The cost of Zepbound with insurance can vary significantly based on an individual's specific insurance plan, including their deductible, copay, and whether Zepbound is covered by their formulary. Some insurance plans may require prior authorization. Eli Lilly offers a savings card that can reduce out-of-pocket costs for eligible commercially insured patients. This card can provide a discount of up to $150 off each prescription, for savings of up to $1,800 per year [2].
What is the price difference between Mounjaro and Zepbound?
Zepbound and Mounjaro are both manufactured by Eli Lilly and contain tirzepatide. Zepbound is FDA-approved for chronic weight management, while Mounjaro is approved for type 2 diabetes. The MSRP for Mounjaro is $987.39 for a one-month supply of pens [3]. Therefore, Zepbound has a higher manufacturer's suggested retail price than Mounjaro.
Can I get a discount on Zepbound?
Yes, eligible commercially insured patients can potentially receive discounts on Zepbound. Eli Lilly's savings card program offers savings of up to $150 off each prescription, up to $1,800 annually [2]. Eligibility requirements and terms apply to this program.
What is the list price of Zepbound?
The list price, or MSRP, for Zepbound is $1,059.87 for a one-month supply of pens [1]. This is the price before any insurance benefits or savings programs are applied.
How does Zepbound pricing compare to other weight loss medications?
Compared to other weight loss medications, Zepbound's list price of over $1,000 per month places it among the higher-cost treatment options. The pricing of weight loss medications can vary greatly depending on the drug, its active ingredient, dosage, and whether it is available as a generic. Many new weight loss drugs, particularly GLP-1 receptor agonists, are positioned at a significant monthly cost.
When does Zepbound's patent expire?
Information regarding specific patent expiry dates for Zepbound (tirzepatide) can be found on specialized pharmaceutical patent databases. For example, DrugPatentWatch.com tracks patent information for numerous drugs, including those related to tirzepatide [4]. Patent exclusivity periods are crucial for understanding when generic versions of a drug might become available, potentially impacting pricing.
How does Eli Lilly's pricing strategy for Zepbound compare to competitors?
Eli Lilly's pricing strategy for Zepbound positions it as a premium medication for weight management. The $1,059.87 MSRP [1] is comparable to or higher than many other branded weight loss therapies. Competitors in the weight loss market also have high-cost options, and the actual cost to patients is heavily influenced by insurance coverage and patient assistance programs.
What are the potential out-of-pocket costs for Zepbound without insurance?
Without insurance, the out-of-pocket cost for Zepbound would be the full MSRP, which is $1,059.87 per month for a one-month supply of pens [1]. This figure does not include any additional costs for medical consultations or potential side effect management.
Are there any patient assistance programs for Zepbound?
Eli Lilly offers a savings card for Zepbound that can significantly reduce out-of-pocket costs for eligible commercially insured patients [2]. Information on other potential patient assistance programs may be available through Eli Lilly's patient support services or third-party organizations that assist with medication costs.
How does tirzepatide's pricing compare across different indications (e.g., diabetes vs. weight loss)?
Tirzepatide is marketed under two different brand names for different indications: Mounjaro for type 2 diabetes and Zepbound for weight management. While both contain the same active ingredient, Zepbound has a higher MSRP ($1,059.87 per month) [1] compared to Mounjaro ($987.39 per month) [3]. This difference in pricing reflects the distinct markets and FDA approvals for each drug.
*
**Sources:
[1] https://www.zepbound.com/pricing
[2] https://www.zepbound.com/savings-card
[3] https://www.mounjaro.com/patients/how-to-get-mounjaro/cost-and-insurance
[4] https://drugpatentwatch.com